Vertex non-opioid painkiller posts positive mid-stage trial results
The results support Vertex's hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results support Vertex's hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.
The results support Vertex’s hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.
Vertex's COO said a trial of its new pain pill hadn't tested the drug against a placebo.
Operator: Welcome to the Invivyd Third Quarter 2023 Financial Results and Recent Business Highlights Call. [Operator Instructions] Please be advised that today's conference call is being recorded.
Rushmie Nofsinger: Good morning. I'm Rushmie Nofsinger, Vice President of Corporate Affairs and Investor Relations at Scholar Rock.